Mohammadmahdi Topaheidari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammadmahdi Topaheidari has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amir Shamloo
Sharif University of Technology
4 shared publications Amirreza Khodayari
4 shared publications- Sina Ebrahimi
Sharif University of Technology
3 shared publications Amir Shamloo
2 shared publicationsAmirmahdi Jafari
2 shared publications- Amirreza Khodayari2 shared publications
Latest Publications
- 27 October 2026
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (44) , 32523-32541
Curved Omega: A High-Performance and Cost-Effective Microfluidic Platform for Circulating Tumor Cell Isolation
The reliable separation of circulating tumor cells (CTCs) from peripheral blood is essential for the detection of cancer at an early stage, assessment of treatment effectiveness, and realization of personalized medicine approaches. Inertial microfluidics has become one promising technique because of its ability to provide a high-throughput process along with label-free manipulation. Nevertheless, conventional devices are frequently hindered by limitations including limited efficiency of isolation, vulnerability to flow instability, and difficulties with scaling up. To address these challenges, the current research investigates a curved Omega inertial microfluidic architecture that employs a curved spiral geometry with repeated Omega-shaped sections to enhance CTC separation. In this case, the proposed microdevice was developed through comprehensive finite element method (FEM) simulations and surrogate modeling analysis of important design factors, including flow rates at the inlets, aspect ratio (AR), microchannel radius (R1), and Omega radius (R2). As a result, a more effective separation along with increased purity of collected samples were obtained for optimal configurations (sample flow rate: 0.94 mL/min; sheath flow rate: 1.56 mL/min; R1 = 4.0 mm, R2 = 0.5 mm, AR = 0.5) with 100% numerical separation efficiency and purity. The performance of the proposed microfluidic system was experimentally evaluated using fabricated microfluidic devices and 4′,6-diamidino-2-phenylindole (DAPI)-stained MCF-7 cancer cells as CTC models. A separation efficiency of 93.3% and a purity rate of 91.7% were observed from the experiment. In addition, approximately 94% of the examined postseparation MCF-7 cells remained attached and exhibited spread morphology consistent with short-term viability after 48 h of culture. The separation mechanism of the curved Omega platform is label-free and relies on passive hydrodynamic forces without external field-based actuation; however, the experimental validation in this study involved a 40-fold dilution of the blood sample with phosphate-buffered saline (PBS) as a sample-preparation step.
- 27 October 2026
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (44) , 32523-32541
Curved Omega: A High-Performance and Cost-Effective Microfluidic Platform for Circulating Tumor Cell Isolation
The reliable separation of circulating tumor cells (CTCs) from peripheral blood is essential for the detection of cancer at an early stage, assessment of treatment effectiveness, and realization of personalized medicine approaches. Inertial microfluidics has become one promising technique because of its ability to provide a high-throughput process along with label-free manipulation. Nevertheless, conventional devices are frequently hindered by limitations including limited efficiency of isolation, vulnerability to flow instability, and difficulties with scaling up. To address these challenges, the current research investigates a curved Omega inertial microfluidic architecture that employs a curved spiral geometry with repeated Omega-shaped sections to enhance CTC separation. In this case, the proposed microdevice was developed through comprehensive finite element method (FEM) simulations and surrogate modeling analysis of important design factors, including flow rates at the inlets, aspect ratio (AR), microchannel radius (R1), and Omega radius (R2). As a result, a more effective separation along with increased purity of collected samples were obtained for optimal configurations (sample flow rate: 0.94 mL/min; sheath flow rate: 1.56 mL/min; R1 = 4.0 mm, R2 = 0.5 mm, AR = 0.5) with 100% numerical separation efficiency and purity. The performance of the proposed microfluidic system was experimentally evaluated using fabricated microfluidic devices and 4′,6-diamidino-2-phenylindole (DAPI)-stained MCF-7 cancer cells as CTC models. A separation efficiency of 93.3% and a purity rate of 91.7% were observed from the experiment. In addition, approximately 94% of the examined postseparation MCF-7 cells remained attached and exhibited spread morphology consistent with short-term viability after 48 h of culture. The separation mechanism of the curved Omega platform is label-free and relies on passive hydrodynamic forces without external field-based actuation; however, the experimental validation in this study involved a 40-fold dilution of the blood sample with phosphate-buffered saline (PBS) as a sample-preparation step.
- 10 October 2026
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 65 (41) , 22179-22193
Sinuspiral Microchannel: A Novel Inertial Microfluidic Device for High-Efficiency Isolation of Circulating Tumor Cells
Effective separation of circulating tumor cells (CTCs) from white blood cells (WBCs) plays a vital role in enhancing cancer diagnosis, assessing treatment effectiveness, and promoting progress in personalized medicine development. Inertial microfluidic systems have recently emerged as an attractive method for cell sorting, offering marker-independent and large-scale separation performance while maintaining the physiological integrity of the cells. Nevertheless, traditional designs often encounter trade-offs between separation performance, flow stability, and device compactness. To address these limitations, the present research proposes a novel microfluidic platform, named Sinuspiral, which is designed with optimized geometrical features to improve the efficiency of CTC separation. The proposed microchannel was optimized using finite element method (FEM) simulations, where key parameters─including inlet flow rates, aspect ratio, U-shaped curvature radius, radius ratio, and number of loops─were systematically analyzed to maximize separation performance. Simulation outcomes revealed that the influence of curvature and the induced secondary flow structures are essential for attaining precise, size-dependent cell separation. When functioning at optimal parameters─comprising a sample flow rate of 0.09 mL/min, a sheath flow rate of 0.18 mL/min, an aspect ratio of 0.5, a U-shaped curvature radius of 100 μm, a radius ratio of 0.03, and seven channel loops─the developed microchannel achieved a separation purity and efficiency of 100% in simulation analyses. Experimental verification conducted with manufactured Sinuspiral microchips and biological samples comprising WBCs and MCF-7 cells (serving as CTC models) demonstrated the device’s strong operational capability, attaining a separation purity of 93.0 ± 2.7% and an efficiency of 96.7 ± 1.6%. These findings highlight the Sinuspiral system’s promise as a highly efficient and economically viable platform for isolating rare circulating cells. This study lays the groundwork for future progress in inertial microfluidic technologies, offering a practical and efficient platform for biomedical and clinical uses, with specific significance for CTC enrichment and cancer diagnosis.
- 10 October 2026
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 65 (41) , 22179-22193
Sinuspiral Microchannel: A Novel Inertial Microfluidic Device for High-Efficiency Isolation of Circulating Tumor Cells
Effective separation of circulating tumor cells (CTCs) from white blood cells (WBCs) plays a vital role in enhancing cancer diagnosis, assessing treatment effectiveness, and promoting progress in personalized medicine development. Inertial microfluidic systems have recently emerged as an attractive method for cell sorting, offering marker-independent and large-scale separation performance while maintaining the physiological integrity of the cells. Nevertheless, traditional designs often encounter trade-offs between separation performance, flow stability, and device compactness. To address these limitations, the present research proposes a novel microfluidic platform, named Sinuspiral, which is designed with optimized geometrical features to improve the efficiency of CTC separation. The proposed microchannel was optimized using finite element method (FEM) simulations, where key parameters─including inlet flow rates, aspect ratio, U-shaped curvature radius, radius ratio, and number of loops─were systematically analyzed to maximize separation performance. Simulation outcomes revealed that the influence of curvature and the induced secondary flow structures are essential for attaining precise, size-dependent cell separation. When functioning at optimal parameters─comprising a sample flow rate of 0.09 mL/min, a sheath flow rate of 0.18 mL/min, an aspect ratio of 0.5, a U-shaped curvature radius of 100 μm, a radius ratio of 0.03, and seven channel loops─the developed microchannel achieved a separation purity and efficiency of 100% in simulation analyses. Experimental verification conducted with manufactured Sinuspiral microchips and biological samples comprising WBCs and MCF-7 cells (serving as CTC models) demonstrated the device’s strong operational capability, attaining a separation purity of 93.0 ± 2.7% and an efficiency of 96.7 ± 1.6%. These findings highlight the Sinuspiral system’s promise as a highly efficient and economically viable platform for isolating rare circulating cells. This study lays the groundwork for future progress in inertial microfluidic technologies, offering a practical and efficient platform for biomedical and clinical uses, with specific significance for CTC enrichment and cancer diagnosis.
- 1 March 2025
- Published by AIP Publishing in Physics of Fluids
- Vol. 37 (3)
Square-based spiral microchannel for the separation of circulating tumor cells using surrogate optimization based on the inertial method
Detecting circulating tumor cells (CTCs) in cancer patients’ blood and distinguishing them from blood cells are crucial for early cancer diagnosis and controlling therapy effectiveness. Scientists have increasingly turned to microfluidic devices to achieve this separation. Various methods exist for separating CTCs from blood cells, including the use of inertial forces, which is a well-established technique based on cell size. Although numerous computational and experimental investigations have been studied on circle-base spiral microchannel, the effect of the spiral's shape has not been extensively explored during separation. This study introduces a square-based spiral microchannel for label-free and rapid separation of CTCs. In addition, the effect of geometric parameters [i.e., the radius of fillet (R), number of fillets and aspect ratio (AR)] and practical parameters (i.e., Reynolds number for sample and sheath flow) have been investigated. Efficiency and purity are significant parameters that demonstrate the performance of the microchannel. The results showed that at Re = 6 for sample inlet and Re = 15 for sheath flow inlet with eleven fillets the efficiency was 100%, and the purity was over 90% of CTCs. Furthermore, surrogate optimization was employed to investigate the performance of the microchannel for different sizes of cancer cells (12–30 μm) and optimize the AR and R. The square cross section (AR = 1) and R = 150 μm yielded high efficiency and purity.
- 1 March 2025
- Published by AIP Publishing in Physics of Fluids
- Vol. 37 (3)
Square-based spiral microchannel for the separation of circulating tumor cells using surrogate optimization based on the inertial method
Detecting circulating tumor cells (CTCs) in cancer patients’ blood and distinguishing them from blood cells are crucial for early cancer diagnosis and controlling therapy effectiveness. Scientists have increasingly turned to microfluidic devices to achieve this separation. Various methods exist for separating CTCs from blood cells, including the use of inertial forces, which is a well-established technique based on cell size. Although numerous computational and experimental investigations have been studied on circle-base spiral microchannel, the effect of the spiral's shape has not been extensively explored during separation. This study introduces a square-based spiral microchannel for label-free and rapid separation of CTCs. In addition, the effect of geometric parameters [i.e., the radius of fillet (R), number of fillets and aspect ratio (AR)] and practical parameters (i.e., Reynolds number for sample and sheath flow) have been investigated. Efficiency and purity are significant parameters that demonstrate the performance of the microchannel. The results showed that at Re = 6 for sample inlet and Re = 15 for sheath flow inlet with eleven fillets the efficiency was 100%, and the purity was over 90% of CTCs. Furthermore, surrogate optimization was employed to investigate the performance of the microchannel for different sizes of cancer cells (12–30 μm) and optimize the AR and R. The square cross section (AR = 1) and R = 150 μm yielded high efficiency and purity.
- 1 March 2025
- Published by AIP Publishing in Physics of Fluids
- Vol. 37 (3)
Passive particle separation using an omega-shaped serpentine channel: Numerical study and surrogate model optimization with experimental validation
The presence of circulating tumor cells (CTCs) in the bloodstream of patients with cancer offers crucial insights into cancer progression and early diagnosis. In recent research, the detection and separation of CTCs using microfluidic devices have become as a primary point of interest, primarily because of their cost-effectiveness and facile implementation. This study introduces an omega-shaped microfluidic device designed for label-free and rapid enrichment of CTCs. Initial investigations employed numerical simulations to optimize the device geometry for enhanced separation quality. The numerical results indicated that a configuration featuring seven Omega channels at a velocity of 0.5 m/s achieved optimal separation, yielding a 100% recovery rate and 96.8% purity of CTCs. Subsequently, a device comprising seven Omega channels was constructed to evaluate the impact of varying flow velocities on CTC separation from blood cells. Experimental findings revealed that a flow velocity of 0.5 m/s facilitated optimal separation efficiency. Notably, the experimental results demonstrated an 88.8% recovery rate and 83.7% purity for CTCs, aligning with the numerical predictions. Furthermore, surrogate modeling was employed to explore the range of cancer cell types and optimize the aspect ratio parameter. The numerical results indicated an optimal aspect ratio of 0.2 within the designed microchannel, resulting in superior separation performance. In addition, it was observed that CTCs with a diameter greater than 20 μm achieved a 100% recovery rate with a purity of over 97%.
- 1 March 2025
- Published by AIP Publishing in Physics of Fluids
- Vol. 37 (3)
Passive particle separation using an omega-shaped serpentine channel: Numerical study and surrogate model optimization with experimental validation
The presence of circulating tumor cells (CTCs) in the bloodstream of patients with cancer offers crucial insights into cancer progression and early diagnosis. In recent research, the detection and separation of CTCs using microfluidic devices have become as a primary point of interest, primarily because of their cost-effectiveness and facile implementation. This study introduces an omega-shaped microfluidic device designed for label-free and rapid enrichment of CTCs. Initial investigations employed numerical simulations to optimize the device geometry for enhanced separation quality. The numerical results indicated that a configuration featuring seven Omega channels at a velocity of 0.5 m/s achieved optimal separation, yielding a 100% recovery rate and 96.8% purity of CTCs. Subsequently, a device comprising seven Omega channels was constructed to evaluate the impact of varying flow velocities on CTC separation from blood cells. Experimental findings revealed that a flow velocity of 0.5 m/s facilitated optimal separation efficiency. Notably, the experimental results demonstrated an 88.8% recovery rate and 83.7% purity for CTCs, aligning with the numerical predictions. Furthermore, surrogate modeling was employed to explore the range of cancer cell types and optimize the aspect ratio parameter. The numerical results indicated an optimal aspect ratio of 0.2 within the designed microchannel, resulting in superior separation performance. In addition, it was observed that CTCs with a diameter greater than 20 μm achieved a 100% recovery rate with a purity of over 97%.